USFDA Inspection at Alembic Pharma's API facility at Karkhadi

USFDA Inspection at Alembic Pharma's API facility at Karkhadi

The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Karkhadi from January 13-17, 2020.

This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations.

Stock view:

On Monday’s trade, Alembic Pharmaceuticals Ltd ended at Rs600, up by Rs1.25 or 0.21% from its previous closing of Rs598.75 on the BSE.

The scrip opened at Rs600 and touched a high and low of Rs600 and Rs600 respectively.

About Gosip4U

Gosip4U is the digital wing of india - India's leading media and communications group with its interests spanning across country.